Literature DB >> 20778066

THE SERUM TREATMENT OF LOBAR PNEUMONIA: A REPORT OF THE THERAPEUTIC TRIALS COMMITTEE OF THE MEDICAL RESEARCH COUNCIL.

.   

Abstract

Year:  1934        PMID: 20778066      PMCID: PMC2444419     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  Why transition from alternation to randomisation in clinical trials was made.

Authors:  I Chalmers
Journal:  BMJ       Date:  1999-11-20

2.  The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries.

Authors:  Iain Chalmers; Estela Dukan; Scott Podolsky; George Davey Smith
Journal:  J R Soc Med       Date:  2012-05       Impact factor: 5.344

3.  Randomization for concealment.

Authors:  David R Cox
Journal:  J R Soc Med       Date:  2010-02       Impact factor: 5.344

4.  Why the MRC therapeutic trials committee did not introduce controlled clinical trials.

Authors:  Ben Toth
Journal:  J R Soc Med       Date:  2015-12       Impact factor: 5.344

5.  The use of historical controls and concurrent controls to assess the effects of sulphonamides, 1936-1945.

Authors:  Irvine Loudon
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

6.  Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial.

Authors:  Scott H Podolsky
Journal:  J R Soc Med       Date:  2009-05       Impact factor: 5.344

7.  UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition.

Authors:  Iain Chalmers
Journal:  J R Soc Med       Date:  2013-12       Impact factor: 5.344

8.  James Angus Doull and the well-controlled common cold.

Authors:  Harry M Marks; A E Williams
Journal:  J R Soc Med       Date:  2008-10       Impact factor: 5.344

9.  Controlled trials: the 1948 watershed.

Authors:  R Doll
Journal:  BMJ       Date:  1998-10-31

10.  The Medical Research Council and clinical trial methodologies before the 1940s: the failure to develop a 'scientific' approach.

Authors:  Linda Bryder
Journal:  J R Soc Med       Date:  2011-08       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.